Patents 20show all

  • 3
    C07D - Heterocyclic compounds
  • 2
    A61K - Preparations for medical, dental, or toilet purposes
  • 2
    C09B - Organic dyes or closely-related compounds for producing dyes

SEC Filings show all


3
D

Contact Information

Towson, MD
United States

SEC Form D Funding Events

DateOfferedSoldType
2013-01-31$1,800,000$1,558,429Debt
2010-06-24$14,475,000$13,012,475Equity
2009-09-10$17,502,000$4,161,000Equity

Key Executives

  • Gary Lessing
    Executive Officer, Director
  • Geeta Vemuri
    Director
  • Phillipe Walker
    Director
  • Philip Goelet
    Director
  • Stephen Roth
    Executive Officer, Director
  • Peter Suzdak
    Executive Officer
  • David Zopf
    Executive Officer
  • Leonard Patrick Gage
    Director
  • Zev Scherl
    Director
  • Philippe Walker
    Director
  • Brian Halak
    Director
  • Mark Strobeck
    Executive Officer, Director
  • David King
    Director
  • Peter Greenleaf
    Director
  • Anne Shiflett
    Executive Officer